Miguel F Sanmamed

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Squamous Cell Carcinoma

Advanced Non Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Paolo Antonio Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero Bermejo, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial. Nature communications 15 (1) (2024)
Paolo Antonio Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero Bermejo, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial. Nature communications 15 (1) (2024)
Ignacio Melero Bermejo, Miguel F Sanmamed, Javier Glez-Vaz, Carlos Luri-Rey, Jun Wang, Lieping Chen
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary. Cancer discovery 13 (3) (2023)
Ignacio Melero Bermejo, Miguel F Sanmamed, Javier Glez-Vaz, Carlos Luri-Rey, Jun Wang, Lieping Chen
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary. Cancer discovery (2022)
Fei Shu, Salman R Punekar, Vamsidhar Velcheti, Miguel F Sanmamed, Jun Wang
PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Irene Olivera, Vicente Martín, Elixabet Bolaños, Inmaculada Rodriguez, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Saray Garasa, Itziar Migueliz, Iñaki Eguren, Miguel F Sanmamed, Javier Glez-Vaz, Arantza Azpilikueta, Maite Alvarez, María Carmen Ochoa, Beatrice Malacrida, David J Propper, Carlos E De Andrea, Pedro Berraondo, Frances R Balkwill, Alvaro Teijeira, Ignacio Melero Bermejo
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β. Cancer discovery 12 (9) (2022)
Assunta Cirella, Elixabet Bolaños, Claudia Augusta Di Trani, Carlos E De Andrea, Sandra Sanchez-Gregorio, Iñaki Etxeberría, Jose Gonzalez-Gomariz, Irene Olivera, Davide Brocco, Javier Glez-Vaz, Carlos Luri-Rey, Arantza Azpilikueta, Inmaculada Rodriguez, Myriam Fernandez-Sendin, Josune Egea, Iñaki Eguren, Miguel F Sanmamed, Belen Palencia, Alvaro Teijeira, Pedro Berraondo, Ignacio Melero Bermejo
Intratumoral gene transfer of mRNAs encoding interleukin-12 in combination with decoy-resistant interleukin-18 improves local and systemic antitumor immunity. Cancer immunology research (2022)
Paolo Antonio Ascierto, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen J Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Marcello Curvietto, Ignacio Melero, Giuseppe Palmieri, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Maria E Rodriguez-Ruiz, Miguel F Sanmamed, Irantzu Serrano-Mendioroz, Ignacio Melero
Consolidating Radiotherapy with Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Miguel F Sanmamed, Xinxin Nie, Shruti S Desai, Franz Villaroel-Espindola, Ti Badri, Dejian Zhao, Anthony W Kim, Lan Ji, Tianxiang Zhang, Edward Quinlan, Xiaoxiao Cheng, Xue Han, Matthew D. Vesely, Ala F Nassar, Jingwei Sun, Yu Zhang, Tae Kon Kim, Jun Wang, Ignacio Melero, Roy S Herbst, Kurt A Schalper, Lieping Chen
A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy. Cancer discovery 11 (7) (2021)
Diego Salas-Benito, Jose-Luis Perez-Gracia, Mariano Ponz-Sarvisé, María E Rodriguez-Ruiz, Iván Martínez-Forero, Eduardo Castañón, José M López-Picazo, Miguel F Sanmamed, Ignacio Melero
Paradigms on Immunotherapy Combinations with Chemotherapy. Cancer discovery 11 (6) (2021)
Iñaki Eguren, Miguel F Sanmamed, Sarah B Goldberg, Harriet M Kluger, Miguel A Idoate, Benjamin Y Lu, Jesús Corral, Kurt A Schalper, Roy S Herbst, Ignacio Gil-Bazo
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Diego Salas-Benito, Iñaki Eguren-Santamaria, Miguel F Sanmamed
Senescent T Cells as a Resistance Mechanism to Lung Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Xue Han, Matthew D. Vesely, Wendy Yang, Miguel F Sanmamed, Ti Badri, Jude Alawa, Francesc Lopez, Patricia Gaule, Sang Won Lee, Jian-Ping Zhang, Xinxin Nie, Ala Nassar, Agedi Boto, Dallas B Flies, Linghua Zheng, Tae Kon Kim, Gilbert W Moeckel, Jennifer M McNiff, Lieping Chen
PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus. Science translational medicine 11 (522) (2020)
Alvaro Teijeira, Saray Garasa, María Carmen Ochoa, María Villalba-Esparza, Irene Olivera, Assunta Cirella, Iñaki Eguren, Pedro Berraondo, Kurt A Schalper, Carlos E de Andrea, Miguel F Sanmamed, Ignacio Melero
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2020)
Miguel F Sanmamed, E Esteban, E Uriol, R Zarate, M Capelan, C Muriel, G Crespo, J P Berros, P Pardo-Coto, Q Perez, C Alvarez-Fernández, P Jiménez Fonseca, M Luque, A Astudillo
Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours. Journal of translational medicine 15 (1) (2017)